It is believed, however, that idiopathic Parkinson’s disease is linked to a body’s problems with using a certain protein. Symptoms of Parkinson’s can include tremors, often in the hands or ...

Professor Wenderlein addresses the important and interesting subject of neuroprotective and preventive measures for intervention in the pathophysiological processes of Parkinson's disease.

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...

In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

Discover top medications for 'treating Parkinsons Disease'? This page compiles essential information on generic and brand-name drugs specifically used for Parkinsons Disease treatment.Here ...

Degeneration of this structure is characteristic of Parkinson's disease. In late 2018, Japanese neurosurgeons at Kyoto University Hospital implanted reprogrammed stem cells into the brain of a ...

The Phase 1b open-label trial will assess the safety and tolerability of 13.5 mg/kg/day of GT-02287 for three months in patients with GBA1-PD or idiopathic Parkinson’s disease. Secondary endpoints ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

In December 2024, we received approval to initiate our Phase 1b clinical trial of GT-02287 in people with GBA1 or idiopathic Parkinson’s disease. This followed the completion of our study in healthy ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...